Nationally representative US data show GLP-1RA use rose 230% among adults with diabetes and 643% among those without reported ...

A Georgia woman said her GLP-1 weight loss drug made her blind. She said she took Wegovy to lose a few pounds and ended up ...

GLP-1 compounders find loophole by altering formulations to bypass FDA bans, raising oversight concerns for weight-loss clinics nationwide.

Adolescents and young adults in the U.S. are increasingly using popular GLP-1 weight-loss drugs alone or in conjunction with ...

Their seemingly miraculous properties have been praised by tech CEOs, podcaster Joe Rogan, and celebrities such as Gwyneth Paltrow, Jennifer Aniston, and Kim Kardashian, who says her daily regimen ...

From 2017 to 2022, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) more than doubled, according to a study ...

A new study found a small increase in the risk of a rare type of sudden vision loss among adults taking GLP-1 medications for ...

Even after federal shortages of the most popular weight-loss drugs ended, many medical spas are still selling copycat ...

Research indicates GLP-1RAs may effectively reduce binge eating severity, offering a complementary approach to existing ...

Shortages of the GLP-1 receptor agonists tirzepatide and semaglutide resolved in December 2024 and February 2025, ...

The compounded GLP-1 market continues, even though some suppliers lack sterile-compounding licenses or have faced disciplinary action, and many add ingredients such as B vitamins.

People are continuing to search for lifestyle obesity interventions online even as interest in GLP-1s and other medications ...